Company: INMB
Filing Date: 2025-06-16
Form Type: S-8
Source: 0001213900-25-054427
Chunk: 13

Company: Inmune Bio, Inc.
Filing Date: 2025-06-16
Form: S-8
Chunk 13
---
. |

In addition, we will make copies of this reoffer
prospectus available to the selling stockholders for the purpose of satisfying the reoffer prospectus delivery requirements of the Securities
Act.

State Securities Laws

Under the securities laws of some states, the
shares of common stock may be sold in such states only through registered or licensed brokers or dealers. In addition, in some states
the shares of common stock may not be sold unless the shares have been registered or qualified for sale in the state or an exemption from
registration or qualification is available and is complied with.

Expenses of Registration

We are bearing all costs relating to the registration
of the common stock. The selling stockholders, however, will pay any commissions or other fees payable to brokers or dealers in connection
with any sale of the common stock.

<div align='center'>6

LEGAL MATTERS</div>

The validity of the common stock has been passed
upon by Sichenzia Ross Ference Carmel LLP, New York, New York.

<div align='center'>EXPERTS</div>

The consolidated financial statements of INmune Bio Inc. as of and for
the years ended December 31, 2024 and 2023 appearing in INmune Bio Inc.’s Annual Report on Form 10-K for the year ended December
31, 2024 have been audited by Marcum LLP, as set forth in its report thereon, included therein, and incorporated herein by reference.
Such consolidated financial statements are incorporated herein by reference in reliance upon such report given on the authority of such
firm as experts in accounting and auditing.

<div align='center'>INCORPORATION OF CERTAIN DOCUMENTS by Reference</div>

The SEC, allows us to incorporate by reference
certain of our publicly filed documents into this reoffer prospectus, which means that such information is considered part of this reoffer
prospectus. Information that we file with the SEC subsequent to the date of this reoffer prospectus will automatically update and supersede
this information. We incorporate by reference the documents listed below and any future filings made with the SEC under all documents
subsequently filed by us pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act until the selling stockholders have sold all
of the shares offered hereby or such shares have been deregistered.

| ● | The description of our common stock contained in our Registration Statement on Form 8-A filed with